OCC 0.00% 35.5¢ orthocell limited

Stem Cell Therapy advancements, page-302

  1. 1,381 Posts.
    lightbulb Created with Sketch. 227
    Bedger we are not sick to death of hearing news from you, what would be even better hearing news from our management team, it’s seems they are, as always holding their cards pretty close to their chest, this isn’t good for our share price or confidence in our management team.

    Who are they in talks with about a partnership? Don’t bullshit saying we are in discussions with a few companies about partnering up, this is just basic business PR you could have learnt in high school

    End of financial year, I need to know where they are at with

    Striate+, US partnership

    Ortho-ATI, Australia and US

    Remplir, Australia and US

    Ortho-ACL, Larger Animal study

    How do you convince new investors, update and release this information so we as investors can make decisions about this company

    The Orthocell website is as always a mess, spend some money to fix it up, try to attract new investors







 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
35.5¢
Change
0.000(0.00%)
Mkt cap ! $74.31M
Open High Low Value Volume
36.0¢ 36.5¢ 35.5¢ $65.26K 181.6K

Buyers (Bids)

No. Vol. Price($)
1 56760 36.0¢
 

Sellers (Offers)

Price($) Vol. No.
36.5¢ 5000 1
View Market Depth
Last trade - 15.04pm 28/06/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.